January 2026 in “Figshare” Low-dose oral minoxidil improves hair loss and quality of life in women, with manageable side effects.
January 2026 in “Figshare” Low-dose oral minoxidil improves hair loss and quality of life for women, despite mild unwanted hair growth.
January 2026 in “International Journal of Medicine in Developing Countries” Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.
January 2026 in “Dermatologic Therapy” 0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.
January 2026 in “Dermatologic Therapy” Combining microneedling with 5% minoxidil is a safe and effective treatment for female pattern hair loss, promoting significant hair regrowth.
January 2026 in “International Journal of Endocrinology” Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.
December 2025 in “Pakistan Journal of Health Sciences” Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.
December 2025 in “Journal of Investigative Dermatology” Immune system issues may contribute to female pattern hair loss.
December 2025 in “Journal of Surgery Research and Practice” Accurate positioning in female hairline transplants creates a natural, feminine look.
December 2025 in “Biomedicines” Addressing body image and weight can help improve female sexual dysfunction.
December 2025 in “Lasers in Medical Science” Combining red laser therapy with minoxidil improves hair growth more effectively than minoxidil alone in women with hair loss.
December 2025 in “Actas Dermo-Sifiliográficas” Bicalutamide may improve hair growth in postmenopausal women with mild side effects.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is caused by diet, hormones, and scalp issues, worsened by COVID-19, with treatments like minoxidil and hair transplants available.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is caused by nutritional deficiencies, hormonal imbalances, and stress, with treatments like minoxidil and hair transplants available.
November 2025 in “International Journal of Research in Medical Sciences” Diffuse alopecia in females is often linked to certain medications, diseases, and low hemoglobin, while female pattern hair loss is linked to age, duration, and family history.
November 2025 in “Turkish Journal of Dermatology” FUE technique offers higher satisfaction and broader use for women needing hair transplants.
November 2025 in “Journal of Investigative Dermatology” Estetrol may help prevent hair loss and support hair growth in women.
November 2025 in “Clinical and Translational Medicine” DNAJB9 cfRNA could help diagnose and treat female hair loss.
September 2025 in “Romanian Journal of Medical Practice” Iron deficiency is linked to female pattern hair loss.
September 2025 in “International Journal of Women’s Dermatology” Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.
September 2025 in “Dermatologic Surgery” Combining radiofrequency with minoxidil is more effective for hair regrowth in women than using CO2 with minoxidil.
September 2025 in “JAAD reviews.” Finasteride and dutasteride can improve hair loss in women, but more research is needed.
September 2025 in “Journal of the American Academy of Dermatology” Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.
September 2025 in “Journal of the American Academy of Dermatology” Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.
August 2025 in “JAAD International” Bicalutamide may take longer to work for female hair loss, and higher doses might be needed.
August 2025 in “JAAD International” Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.
Female pattern hair loss and polycystic ovary syndrome are often linked.
August 2025 in “Journal of Investigative Dermatology” Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.
July 2025 in “Dermatology Practical & Conceptual” Spironolactone is safe for treating hair loss in women without causing low blood pressure.
July 2025 in “Journal of Cosmetic Dermatology” Future research on female pattern hair loss should focus on treatment effectiveness, safety, and understanding causes.